309,339 Shares in Danaher Corporation $DHR Purchased by Braidwell LP

Key Points

• Braidwell LP has made a significant investment of $63.41 million in Danaher Corporation, acquiring 309,339 shares in the first quarter, which represents 2.2% of its investment portfolio.
• Wall Street analysts have given Danaher a consensus rating of "Moderate Buy" with an average price target of $247.61, reflecting strong confidence in the company's growth trajectory.
• Despite recent insider selling, which saw Director Teri List reduce her position by 11.81%, institutional ownership remains high at 79.05% of the company's stock.

Braidwell LP bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 309,339 shares of the conglomerate's stock, valued at approximately $63,414,000. Danaher makes up approximately 2.2% of Braidwell LP's investment portfolio, making the stock its 16th largest position.

Other institutional investors and hedge funds have also bought and sold shares of the company. Bank Pictet & Cie Europe AG increased its holdings in shares of Danaher by 22.8% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock valued at $44,241,000 after acquiring an additional 35,730 shares during the period. Gallagher Fiduciary Advisors LLC raised its position in shares of Danaher by 9.7% in the 4th quarter. Gallagher Fiduciary Advisors LLC now owns 1,065 shares of the conglomerate's stock worth $244,000 after acquiring an additional 94 shares in the last quarter. Accredited Wealth Management LLC bought a new position in shares of Danaher in the 4th quarter worth $40,000. Aptus Capital Advisors LLC raised its position in shares of Danaher by 8.6% in the 4th quarter. Aptus Capital Advisors LLC now owns 7,078 shares of the conglomerate's stock worth $1,626,000 after acquiring an additional 562 shares in the last quarter. Finally, Ancora Advisors LLC raised its position in shares of Danaher by 2.2% in the 4th quarter. Ancora Advisors LLC now owns 7,020 shares of the conglomerate's stock worth $1,611,000 after acquiring an additional 149 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the company's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 11.20% of the stock is owned by insiders.

Danaher Stock Performance

Shares of DHR traded down $0.47 during mid-day trading on Thursday, reaching $198.97. The company had a trading volume of 3,627,515 shares, compared to its average volume of 4,153,999. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $142.47 billion, a P/E ratio of 42.33, a PEG ratio of 2.87 and a beta of 0.75. The stock has a 50 day moving average of $201.94 and a two-hundred day moving average of $199.49.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the prior year, the business earned $1.72 earnings per share. The company's revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Analyst Ratings Changes

Several research firms have recently commented on DHR. Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a research report on Friday, July 11th. Evercore ISI dropped their target price on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. Guggenheim restated a "buy" rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Wells Fargo & Company dropped their price target on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $246.35.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.